MBAI: Innovative Strategies & AI-Powered Solutions In a recently published video from Medbright AI Investments (ticker: MBAI.c or MBAIF), CEO Trevor Vieweg and Chairman Dr. Jamie Gerber discuss their innovative strategy in healthcare investment. Positioned at the crossroads of healthcare and technology, MBAI.c aims to harness artificial intelligence (AI) to enhance both patient and physician experiences.
Dr. Jamie Gerber, a seasoned cardiologist with over 30 years of experience, sheds light on the "healthcare waiting room problem" – a trifecta of challenges encompassing appointment scheduling, office navigation, and follow-up care.
Enter MBAI.c, strategically investing in a groundbreaking AI-powered solution – Medmatrix. This data analytics platform revolutionizes clinic operations by predicting resource needs for upcoming visits based on a patient's background, clinical history, and other relevant factors.
The result? A streamlined scheduling process that caters to the unique needs of diverse patients without the need for new software or extensive staff training.
Medmatrix doesn't just reduce physician burnout; it elevates the quality of patient care and opens up new revenue streams for clinics, all while ensuring financial gains without additional costs.
Dr. Gerber hails Medmatrix as a tool that addresses three major clinic challenges: reducing physician burnout, enhancing care quality, and creating new revenue opportunities.
Although MBAI's market capitalization is below $22 million, they have successfully onboarded 14 clinics in just two months. This includes a clinic group associated with the Yale School of Medicine as well as the renowned Rejuvenation Medical Group which spans 9 clinics across 3 provinces, benefiting a diverse team of medical professionals including 5 specialized Mohs surgeons.
Full video here:
Posted on behalf of Medbright AI Investments Inc.